Guru Ownership Trend
Guru Analysis for Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc. (AKBA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.87 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $247,804.78 net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 46.2%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 9.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Akebia Therapeutics, Inc. (AKBA)
Major holders include Renaissance Technologies (RenTech) ($5.78 M), Cliff Asness ($1.04 M), Joel Greenblatt ($25,712). According to the latest reported data, 3 tracked investment managers collectively hold approximately 4.26 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $247,804.78, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited AKBA. The total reported sell value was $578,946.33.
Yes, 0 managers opened new positions in AKBA, and 2 increased their existing holdings. The total reported buy value was $331,141.55.